{Reference Type}: Journal Article
{Title}: Validation of a Core Patient-Reported Outcome Measure for Life Participation in Kidney Transplant Recipients: the SONG Life Participation Instrument.
{Author}: Jaure A;Vastani RT;Teixeira-Pinto A;Ju A;Craig JC;Viecelli AK;Scholes-Robertson N;Josephson MA;Ahn C;Butt Z;Caskey FJ;Dobbels F;Fowler K;Jowsey-Gregoire S;Jha V;Tan JC;Sautenet B;Howell M;
{Journal}: Kidney Int Rep
{Volume}: 9
{Issue}: 1
{Year}: 2024 Jan
{Factor}: 6.234
{DOI}: 10.1016/j.ekir.2023.10.018
{Abstract}: <B>UNASSIGNED: </B>Life participation has been established as a critically important core for trials in kidney transplantation. We aimed to validate a patient-reported outcome measure for life participation in kidney transplant recipients.<BR><B>UNASSIGNED: </B>A psychometric evaluation of the Standardized Outcomes in Nephrology life participation (SONG-LP) measure was conducted in adult kidney transplant recipients. The measure includes 4 items of life participation (leisure, family, work, and social) each with a 5-point Likert scale. Each item is scored from 0 (never) to 4 (always) and the summary measure score the average of each item.<BR><B>UNASSIGNED: </B>A total of 249 adult kidney transplant recipients from 20 countries participated. The SONG-LP instrument demonstrated internal consistency (Cronbach's α = 0.87; 95% confidence intervals [CI]: 0.83-0.90, baseline) and test-retest reliability over 1 week (intraclass correlation coefficient of 0.62; 95% CI: 0.54-0.70). There was moderate to high correlation (0.65; 95% CI: 0.57-0.72) with the PROMIS Ability to Participate in Social Roles and Activities Short Form 8a that assessed a similar construct, and moderate correlation with measures that assessed related concepts (i.e., EQ5D 0.57; 95% CI: 0.49-0.65), PROMIS Cognitive Functional Abilities Subset Short Form 4a (0.40; 95% CI: 0.29-0.50).<BR><B>UNASSIGNED: </B>The SONG-LP instrument is a simple, internally consistent, reliable measure for kidney transplant recipients and correlates with similar measures. Routine incorporation in clinical trials will ensure consistent and appropriate assessment of life participation for informed patient-centered decision-making.